341 related articles for article (PubMed ID: 32215287)
21. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
Neelakantan D; Drasin DJ; Ford HL
Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
[TBL] [Abstract][Full Text] [Related]
22. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
23. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
24. The multiverse nature of epithelial to mesenchymal transition.
Simeone P; Trerotola M; Franck J; Cardon T; Marchisio M; Fournier I; Salzet M; Maffia M; Vergara D
Semin Cancer Biol; 2019 Oct; 58():1-10. PubMed ID: 30453041
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling.
Lin YT; Wu KJ
J Biomed Sci; 2020 Mar; 27(1):39. PubMed ID: 32114978
[TBL] [Abstract][Full Text] [Related]
26. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition.
Cieślik M; Hoang SA; Baranova N; Chodaparambil S; Kumar M; Allison DF; Xu X; Wamsley JJ; Gray L; Jones DR; Mayo MW; Bekiranov S
Epigenetics Chromatin; 2013 Sep; 6(1):28. PubMed ID: 24004852
[TBL] [Abstract][Full Text] [Related]
28. Role of epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G; Koudelkova P; Dituri F; Mikulits W
J Hepatol; 2016 Oct; 65(4):798-808. PubMed ID: 27212245
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries.
Corallino S; Malabarba MG; Zobel M; Di Fiore PP; Scita G
Front Oncol; 2015; 5():45. PubMed ID: 25767773
[TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
32. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Bonavida B; Baritaki S
Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
[TBL] [Abstract][Full Text] [Related]
33. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer.
Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Li X; Liu X; Xu Y
Front Cell Dev Biol; 2020; 8():655. PubMed ID: 32793598
[TBL] [Abstract][Full Text] [Related]
35. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.
Pillai M; Rajaram G; Thakur P; Agarwal N; Muralidharan S; Ray A; Barbhaya D; Somarelli JA; Jolly MK
Front Oncol; 2022; 12():913803. PubMed ID: 36003764
[TBL] [Abstract][Full Text] [Related]
36. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
Klymenko Y; Kim O; Stack MS
Cancers (Basel); 2017 Aug; 9(8):. PubMed ID: 28792442
[TBL] [Abstract][Full Text] [Related]
37. Involvement of partial EMT in cancer progression.
Saitoh M
J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.
Malek R; Wang H; Taparra K; Tran PT
Cells Tissues Organs; 2017; 203(2):114-127. PubMed ID: 28214899
[TBL] [Abstract][Full Text] [Related]
39. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
40. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
